elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Urothelial carcinoma
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Urothelial carcinoma
RIS
0.001
(Research Intensity Score)
Papers
88
Top papers
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update
2023 · 510 citations
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
2020 · 1494 citations
Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial
2025 · 89 citations
LBA6 EV-302/KEYNOTE-A39: Open-label, randomized phase III study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (Chemo) in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC)
2023 · 137 citations
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial
2021 · 279 citations
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial
2020 · 531 citations
The biology and rationale of targeting nectin-4 in urothelial carcinoma
2020 · 201 citations
EV-302: Updated analysis from the phase 3 global study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC).
2025 · 19 citations
Diagnosis and Management of Upper Tract Urothelial Carcinoma: A Review
2025 · 11 citations
Newest papers
Rapid Systemic Progression After Ureteroscopic Holmium: YAG Laser Ablation for High‐Grade Upper Tract Urothelial Carcinoma in a Solitary Kidney: A Case Report
2026 · 1 citations
Intravesical Recurrence of Upper Tract Urothelial Carcinoma: Strategies for Prevention
2026
Integrative Genomic Analysis Reveals Molecular and Clinical Disparities between Bladder and Upper Tract Urothelial Carcinoma in K-MASTER Program
2026
Cost-effectiveness of disitamab vedotin plus toripalimab in HER2-expressing advanced urothelial carcinoma in China
2026
The 2025 paradigm shift in urothelial carcinoma pharmacotherapy: from chemotherapy to ADCs and ICIs
2026
Case report: A case series report: recurrent urolithiasis as a risk factor for upper tract urothelial carcinoma
2026
Editorial Comment on Rapid Systemic Progression After Ureteroscopic Holmium: YAG Laser Ablation for High‐Grade Upper Tract Urothelial Carcinoma in a Solitary Kidney: A Case Report
2026
STR typing from punched FFPE tissues: resolving suspected contamination and fetal–maternal mixture in two cases
2026
PROGNOSTIC VALUE OF THE HALP SCORE IN METASTATIC UROTHELIAL CARCINOMA TREATED WITH FIRST-LINE PLATINUM-BASED CHEMOTHERAPY
2026
Browse all papers →
Urothelial carcinoma's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Urothelial carcinoma's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link